Ozibozi
Posted - 15 hours ago
$ALT check $amam chart…
ViractaTrader77
Posted - 5 days ago
$IMGN $AMAM $VKTX $PYXS Trading beneath cash, tons of big pharma partnerships. 2 folate ADCs acquired in past 18 mos for $12 billion combined.
Could be next major adc acquisition target.
Do your homework on Sutro
https://x.com/BiotechTVHQ/status/1775900116924448891
DaBullRunner
Posted - 1 week ago
Thought I was finished?????
I have enough highlight reels to last years folks
Stay with me on this one…..
Although I didn’t state it I did have an inkling that $AMAM would be bought out around the $12’s You may think I’m making this up but IDGAF what you think I’m telling you these Parkinson’s/ Alzheimer’s tickers could change your entire account around And like I said, $ATHE is not in Phase 1 folks They actually produced positive Phase 2 results
🚨LET THAT SINK IN🚨 The current market cap doesn’t this imo
CHCInvestments
Posted - 1 week ago
$PHAT Any of you guys or gals been in this stock a while and follow it closely? I am just looking for input from people who plan to hold this long term. I had a large position in $AMAM and sold it a short time ago.....and have been sitting on that cash. I would like to put it to work and have been watching this closely. I missed entering last week in mid $9's...but thinking about starting to add this dip and just averaging down if it drops and writing covered calls. Looks like mid $7's would be the very lowest, but mid 9's more likely to get bought up again. I have a bunch of questions....but how about some of you tell me the pros and cons of this company. Looks like around 60M float, good bit of cash, expected revenue, high short %. What kind of revenue they expect in next year or so? Any chance a bigger company buys this out, like happened to AMAM? I appreciate your folks input. Thanks!!
DharlMorey2
Posted - 1 week ago
$ATOS Insider buys at Atossa -- big moves coming. - $SLS looks like it wants to gamma squeeze with the call buying, lack of sellers, and nearly 100% cost-to-borrow for shorts. - $CADL - Probably a buyout candidate, not sure on timeline but reminds me a lot of $AMAM getting scoped up. Bio sector is hot! $XBI
ViractaTrader77
Posted - 1 week ago
$STRO $PYXS $FUSN $AMAM Sutro Bio could be next on big Pharma list.
Immunogen and Profound Bio are similar to sutro’s lead ADC Luvelta in that it binds to the folate receptor. https://www.investopedia.com/genmab-buys-profoundbio-for-usd1-8b-to-boost-oncology-portfolio-8624021
Ridiculous78
Posted - 1 week ago
$ALPN Price action is always telling to a buyout.. Writing was on the wall over at $AMAM and $IMGN as well! $JANX could be next 🤔
DharlMorey2
Posted - 1 week ago
$ATOS Saw the same thing on my $SYRS where it took 2 days for tutes to process the news before a 300% gain. The BIG news: "Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen" ASCO participation is only 14 days away (11 trading days) -- so we're going to know very quickly how big the next round of fireworks are :) May 24th we get the text -- and then a week later Russell 2000/3000 preliminary lists are released -- we may see some serious volume. The news source: https://investors.atossatherapeutics.com/news-releases/news-release-details/atossa-therapeutics-presents-data-40mg-cohort-phase-2-evangeline $XBI $AMAM
DharlMorey2
Posted - 1 week ago
$ATOS Double digits by end of year -- buy and hold “The 40mg EVANGELINE data is extremely encouraging as it shows that (Z)-endoxifen can not only stop ER+ breast cancer from growing, but it can also shrink or eliminate the tumor, as measured by MRI imaging,” said Dr. Steven Quay, Atossa’s President and Chief Executive Officer. “The depth of response at 40mg may even improve in the next phase of the study where we are now treating women with 80mg of (Z)-endoxifen daily. We expect this dose to deliver the optimal steady-state plasma concentrations required to fully target PKCβ1 inhibition and further enhance (Z)-endoxifen’s antitumor efficacy.” $JNJ $PFE $AZN $AMAM
Earth4thewin
Posted - 1 week ago
This man ,Daniel J. O'Connor CEO of AMBRX $AMAM really will be remembered as a successful individual that obviously knows how to run a company . We need more CEOs like this . 👍 W
DharlMorey2
Posted - 1 week ago
$ATOS So many of you got your shares stolen today -- stop losses off for the last time LOL. Ran it down to 1.60 and bounced back up to 2.04 at one point. Buy. Hold. That's it. Read the post and links below if you need some weekend reading on the company. PR coming next week otherwise to help you understand the data. $XBI $VKTX $AMAM $OCEA
DharlMorey2
Posted - 1 week ago
$ATOS We've known most of the results previously (non-toxicity), but now we know anti-tumor activity has been confirmed. 80mg data going to prove us right :) 80mg cohort completion shortly -- run to 3+ soon. All the shorts loading in now going to get burned :) Hope you didn't lose your stop loss https://www.abstractsonline.com/pp8/#!/20272/presentation/11540 $XBI $AMAM $VKTX
DharlMorey2
Posted - 1 week ago
$ATOS "ENDX (40 mg/day) exhibits promising antitumor activity " -- that's all weI needed to hear. $XBI $BKNG $AMAM $VKTX
DharlMorey2
Posted - 1 week ago
$ATOS (Share everywhere!) https://www.abstractsonline.com/pp8/#!/20272/presentation/11540 "Conclusions: ENDX (40 mg/day) exhibits promising antitumor activity for PM ER+/HER2- BC but with ENDX Css below target. Enrollment is ongoing to the 80 mg/day dose level." $XBI $VKTX $AMAM $BKNG
DharlMorey2
Posted - 1 week ago
$AZN $XBI $ATOS $VKTX $AMAM (Actual PR probably coming out Tuesday/Wednesday though after presentation of data)
DharlMorey2
Posted - 1 week ago
$ATOS Yup, stop losses off folks. No reason for them to present and publish bad data. I'm still guessing we'll get an official PR after the presentation around Tuesday (Wednesday morning or Tuesday afternoon then). Some games will be played, but just look at the timeline below -- next catalyst April 24th -- shortly after :) $XBI $OCEA $CADL $AMAM
DharlMorey2
Posted - 1 week ago
$ATOS -- abstract tomorrow! $VKTX $XBI $AMAM $BKNG
RavenHood
Posted - 2 weeks ago
$NKTX this reminds me a lot of $AMAM
DharlMorey2
Posted - 2 weeks ago
$ATOS New all-time highs (9.80+) by Russell Reconstitution day (May 31st). Two data drops plus russell means this is going to run. -- That's not even including the phase-2 MBD that finishes in June, and then the I-Spy 2 phase-2 trial finishing in 2H of 2024. Buy shares now -- hold and be rewarded [1][2] $VKTX $AMAM $XBI $OCEA [1] https://www.youtube.com/watch?v=5-IV3Zofu6c (4 minute video) [2] https://www.youtube.com/watch?v=kYwXmGiIByQ (Another 4 minute video)
DharlMorey2
Posted - 2 weeks ago
$ATOS AACR abstract text tomorrow at 3:30pm EST! PR could be after hours or otherwise on Tuesday. Watching for some heavy volume :) :) Best part is, next catalyst is then April 24th (ASCO Abstract) :) Then rank day comes April 30th for Russell[1] :) ASCO abstract then released May 24th, which is a week before Russell index/deletion lists. Nice timing! Atossa has no debt, 84 million in the bank, no cash raise for 3 years, and more data (see timeline below) all year (including the two phase-2 studies)! $XBI $VKTX $AMAM $OCEA [1] https://www.lseg.com/en/media-centre/press-releases/ftse-russell/2024/russell-reconstitution-2024-schedule
ViractaTrader77
Posted - 2 weeks ago
$AMAM $IMGN $LVTX
DharlMorey2
Posted - 2 weeks ago
$ATOS Volume is 10x what it was nearly a month ago, and also 10x most of 2023 there were only 200-400,000 shares traded daily. This type of volume is institutional accumulation for a big move up. Shorts here will try to scare you into selling -- but they're trapped (could be over 20% now)! Penny flippers are happy with there 5% gains. Longs will be celebrating in less than 7 days on data release potentially new highs since 2021. PT 9.82+ within the next two months -- Data-riven year coming[1], pipeline growing[2] with more combination therapies [3] -- more DD here [4]. Also -- no debt, no cash raise for 3 years (84 million in the bank) $AMAM $VKTX $XBI $OCEA [1] https://www.genomeweb.com/Reprint-GW23002AtossaTherapeutics [2] https://atossatherapeutics.com/product-pipeline/ [3] https://www.youtube.com/watch?v=zOSfo1PQM_4 [4] https://www.proactiveinvestors.com/NASDAQ:ATOS/Atossa-Therapeutics-Inc
doodledo77
Posted - 2 weeks ago
$ATOS $XBI $GME $AMAM $VKTX Going to be a huge spike for Atos... Two phase 2 in the pipeline coming 🙏
DharlMorey2
Posted - 2 weeks ago
$ATOS Short interest of nearly 25 million shares[1]? That's closer to around 20% of the float (Float is about 126 million: https://finviz.com/quote.ashx?t=ATOS&p=d) Shorts about to get blown away considering data is coming on either the 5th or the 9th of April. What are they doing LOL! $XBI $GME $AMAM $VKTX [1] https://app.ortex.com/s/Nasdaq/ATOS/short-interest
DharlMorey2
Posted - 2 weeks ago
$ATOS I saw (from different sources) short interest increased 16% and days to cover was well over 9 (9.87 iirc). Basically -- when the data comes in, we could see a short squeeze. Stop losses off folks! $XBI $GME $AMAM $VKTX
DharlMorey2
Posted - 2 weeks ago
$ATOS We're currently ranked 3500 -- you subtract out the 500 companies (S&P 500), and we're going to be included in the Russell 3000. Other Microcap indexes will also have to start buying heavy into Atossa. With the data release, I think we will surpass 2021 highs of 9.82+, and then also get inclusion in the Russell 2000. Buy & Hold -- Stop Losses off if you want to keep your shares https://stockanalysis.com/list/biggest-companies/ $VKTX $AMAM $AZN $PFE
DharlMorey2
Posted - 2 weeks ago
$ATOS One more reason this is going to run to new all-time highs well into September "As of September 10, 2024, the U.S. Food and Drug Administration (FDA) will require mammogram providers to notify patients about the density of their breasts. The notification for patients with dense breasts will include a warning that dense tissue makes it" https://investors.atossatherapeutics.com/node/10896/html $VKTX $AMAM $AZN $PFE
DharlMorey2
Posted - 2 weeks ago
$ATOS For new folks to review the catalysts! $XBI $VKTX $OCEA $AMAM